Clinical Trials Logo

Alcoholic Intoxication clinical trials

View clinical trials related to Alcoholic Intoxication.

Filter by:

NCT ID: NCT05701865 Recruiting - Clinical trials for Alcohol Intoxication

Biphasic Effects of Acute Alcohol Intoxication on Bystander Intervention

Start date: March 9, 2023
Phase: N/A
Study type: Interventional

The goal of this experimental study is to examine the effect of alcohol, gender, and bystander attitudes on bystander barriers and sexual violence intervention among young adult men and women (age 21-20). The main questions it aims to answer are: - Does alcohol intoxication and gender influence bystander barriers and sexual violence intervention? - Does alcohol intoxication have a greater impact on bystander barriers and sexual violence intervention among men, compared to women? - Does alcohol intoxication have a greater impact on bystander barriers and sexual violence intervention among those with higher, compared to lower, prosocial bystander attitudes? Participants will be randomly assigned to one of two beverage conditions (alcohol or control beverage) and those assigned to alcohol will complete the study on either the ascending or descending alcohol limb. Participants will project themselves into a heat-of-the moment, risky sexual violence scenario that will assess bystander barriers and behavioral intentions. Researchers will compare those assigned to the alcohol and control beverage condition and men/women to see if this impacts bystander barriers and sexual violence intervention.

NCT ID: NCT05692830 Recruiting - Alcohol Drinking Clinical Trials

Towards a Wearable Alcohol Biosensor: Examining the Accuracy of BAC Estimates From New-Generation Transdermal Technology Using Large-Scale Human Testing and Machine Learning Algorithms

Start date: April 3, 2022
Phase: N/A
Study type: Interventional

The study will employ a combined laboratory-ambulatory design. Participants will engage in ambulatory assessment over the course of 14 days, wearing biosensors assessing transdermal alcohol concentration (TAC) and providing breathalyzer readings in real-world contexts. Also during this period, participants will attend three laboratory alcohol-administration sessions scheduled at one-week intervals, with alcohol dose and rate of consumption manipulated within and between participants, respectively. Laboratory visits will also double as ambulatory orientation, check-in, and close-out sessions.

NCT ID: NCT05491551 Recruiting - Binge Drinking Clinical Trials

Alcohol-ROC-Training

A-ROC-T
Start date: September 28, 2022
Phase: N/A
Study type: Interventional

The goal of the proposed study is to examine whether brief training in regulation of craving (ROC-T) affects alcohol drinking. The study will consist of a basic screening (phone and online), and in person visit to determine eligibility and conduct pre-intervention baseline assessments, 1-4 training (ROC-T) visits, a post-intervention assessment visit, and 1-2 phone/online follow up assessments.The two active conditions of ROC-T are based on cognitive-behavioral treatments (CBT) and mindfulness-based treatments (MBT).

NCT ID: NCT05360888 Recruiting - Suicidal Ideation Clinical Trials

Suicide Intervention for Alaska Native Youth

BeWeL
Start date: December 22, 2022
Phase: N/A
Study type: Interventional

Two interventions will be delivered virtually to American Indian/Alaska Native youth who have been hospitalized with suicidal attempt, suicidal ideation, or associated risk behaviors, including alcohol-related injury.

NCT ID: NCT05273658 Withdrawn - Clinical trials for Alcohol Intoxication

Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests

Start date: August 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The overarching aim of this study is to examine the impact of acute cannabis and alcohol administration on driving performance, as well as identify methods for detecting driving under the influence of these substances. One-hundred twenty-five healthy volunteers will be randomized into one of 5 conditions; those who receive 1) low dose alcohol and placebo cannabis, 2) low dose alcohol and tetrahydrocannabinol (THC), 3) high dose alcohol and placebo cannabis, 4) placebo alcohol and THC, and 5) double placebo. Cannabis inhaled ad libitum and/or ingested alcohol will take place at the beginning of the day followed by the completion of driving simulations, components of the Drug Recognition Expert (DRE) evaluations, and bodily fluid draws (e.g., blood, oral fluid/saliva, breath) over the subsequent 4 hours after ingestion. The purpose of this study is to determine (1) the impact of Δ9-THC on driving performance with and without concurrent alcohol ingestion (2) the duration of driving impairment in terms of hours from initial use, (3) the relationship between performance on the DRE measures and cannabis/alcohol ingestion, and 4) if saliva or expired air can serve as a useful adjunct to the field for blood sampling.

NCT ID: NCT05173116 Withdrawn - Emergencies Clinical Trials

Evaluation of the API-VIGIE Monitoring System: Program to Reduce Emergency Visits for Severe Paroxysmal Alcoholism

EVAL-APIVIGIE
Start date: February 2022
Phase:
Study type: Observational

The study was designed to evaluate the APIVIGIE program use at CH d'Arras. The objective of this program is to reduce repeated visits by the same patient to the emergency room for Alcoholism Severe Paroxysmal

NCT ID: NCT05028413 Completed - Alcohol Drinking Clinical Trials

Evaluating Perceived Fitness to Drive While Intoxicated

Start date: May 8, 2017
Phase: N/A
Study type: Interventional

The goal of this study is to conduct a laboratory-based pilot randomized control trial of smartphone-enabled breath alcohol monitoring on perceived fitness to drive a vehicle among intoxicated adults. The study team will enroll up to 30 adults aged > 21-44 who are frequent drinkers without dependence who drive more than four times per week to complete a standardized alcohol drinking protocol in a monitored setting collecting breathalyzer measurements. The protocol involves consuming three weight-based doses of alcohol with a target BAC of 0.10 and completing breathalyzer measurements every 20 minutes until a BAC of 0.03 is reached. The control group will complete a visual analog scale on their perceived fitness to drive and be blinded to their breath alcohol readings with the BACtrack Mobile Pro breathalyzer device, while the intervention group would do the same, but be shown their breath alcohol readings on the paired BACtrack smartphone application. The research team's previous research has validated the accuracy of the BACtrack Mobile Pro device to measure BAC within +/- 0.001 of police-grade breathalyzer and estimate BAC within +/- 0.01 of a blood test.

NCT ID: NCT04949711 Recruiting - Alcohol Drinking Clinical Trials

Impacts of Subsidized Ridesharing on Drunk Driving, Alcohol Consumption, and Mobility

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this research study is to understand people's alcohol use in public places and their risks for harm. The overall goal of this study is to test the effects of subsidized ridesharing as an intervention to reduce self-reported alcohol-impaired driving, along with alcohol consumption and changes to mobility.

NCT ID: NCT04931095 Recruiting - Clinical trials for Alcohol Intoxication

The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment

Start date: February 17, 2022
Phase: Phase 1
Study type: Interventional

This study will evaluate the individual and interactive effects of oral cannabis and alcohol on subjective and behavioral measures of impairment.

NCT ID: NCT04912492 Recruiting - Sexual Violence Clinical Trials

Promoting Prosocial Bystander Behavior in Intoxicated Men: Evaluation of RealConsent2.0

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Sexual violence (SV) is a significant public health problem particularly among 18-24 year old populations. A major risk factor for SV is alcohol use, which via its negative impact on cognitive abilities and decision-making acts as a barrier to intervening in situations at-risk for a SV. This study has two main goals: (1) to determine the effects of proximal alcohol use on young (age 21 to 25) men's prosocial bystander behavior in situations considered at-risk for SV, and (2) to determine the efficacy of an evidence-based, web-based program called RealConsent, which has been augmented to include alcohol-specific content within the context of bystander SV ("RealConsent2.0"), on men's prosocial bystander behavior. The primary study endpoint is prosocial bystander behavior and will be assessed via two modes: (1) a virtual reality (VR) environment ("B-SAVE") and (2) a validated self-report measure of bystander behavior that has been modified to include assessment of proximal alcohol use and presence of alcohol within the context.